Diamyd Medical AB | |
Stock Exchange | First North Sweden |
EPS |
SEK0.68 |
Market Cap |
SEK451.8 M |
Shares Outstanding |
54.2 M |
Public Float |
- |
Address |
Kungsgatan 29 Stockholm AB 111 56 Sweden |
Employees | - |
Website | http://www.diamyd.com |
Updated | 09/14/2018 |
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes. It develops vaccine to cure autoimmune diabetes. The firm also involves in investment in medical and stem cell technology. |